Last $1,491 MXN
Change Today 0.00 / 0.00%
Volume 0.0
MON* On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
As of 4:08 PM 10/17/14 All times are local (Market data is delayed by at least 15 minutes).

monsanto co (MON*) Snapshot

Open
$1,491
Previous Close
$1,491
Day High
$1,491
Day Low
$1,491
52 Week High
07/2/14 - $1,660
52 Week Low
11/12/13 - $1,410
Market Cap
782.1B
Average Volume 10 Days
41.4
EPS TTM
--
Shares Outstanding
524.6M
EX-Date
10/8/14
P/E TM
--
Dividend
$1.95
Dividend Yield
1.57%
Current Stock Chart for MONSANTO CO (MON*)

monsanto co (MON*) Details

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds principally under the DEKALB, Channel, Asgrow, and Deltapine brands; and vegetable seeds consisting of tomato, pepper, melon, cucumber, pumpkin, squash, beans, broccoli, onions, and lettuce seeds under the Seminis and De Ruiter brands. This segment also develops biotechnology traits that assist farmers in controlling insects and weeds in corn, cotton, and soybean crops under the SmartStax, YieldGard, YieldGard VT Triple, VT Triple PRO, and VT Double PRO, as well as Intacta RR2 PRO, Bollgard and Bollgard II, Roundup Ready and Roundup Ready 2 Yield, and Genuity brands; and licenses a range of germplasm and trait technologies to seed companies. The Agricultural Productivity segment manufactures and sells herbicides for agricultural, industrial, ornamental, turf, and residential lawn and garden applications for weed control, as well as for control of preemergent annual grass and small seeded broadleaf weeds in corn and other crops under the Roundup and Harness brands. The company sells its products through distributors, independent retailers and dealers, agricultural co-operatives, plant raisers, and agents, as well as directly to farmers. It has operations primarily in the United States, Europe, Africa, Brazil, the Asia-Pacific, Argentina, Canada, and Mexico. Monsanto Company has a strategic alliance with Novozymes A/S to discover, develop, and sell microbial solutions for farmers. The company was formerly known as Monsanto Ag Company and changed its name to Monsanto Company in March 2000. Monsanto Company was incorporated in 2000 and is headquartered in St. Louis, Missouri.

20,000 Employees
Last Reported Date: 10/8/14
Founded in 2000

monsanto co (MON*) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.5M
President and Chief Operating Officer
Total Annual Compensation: $683.8K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $569.6K
Chief Technology Officer and Executive Vice P...
Total Annual Compensation: $632.6K
Executive Vice President, General Counsel and...
Total Annual Compensation: $530.8K
Compensation as of Fiscal Year 2013.

monsanto co (MON*) Key Developments

Monsanto Announces Executive Changes

Monsanto appointed Leticia Gonçalves as president of its European Row Crops business, taking over from José Manuel Madero who was recently appointed as International Business Development head to focus on the empowerment of small-holder farmers. Also, Gonçalves joins the company's International Business Leadership team and will oversee its Row Crops business in Europe and the Middle East, which is focused on sales of conventional maize and oilseed rape seeds and agricultural productivity products like Roundup. Most recently, Gonçalves was with Monsanto in the U.S., where she headed the company's U.S. Row Crops Commercial Operations.

Monsanto Company Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended August 31, 2014; Provides Earnings Guidance for Fiscal 2015

Monsanto Company reported unaudited consolidated earnings results for the fourth quarter and full year ended August 31, 2014. For the quarter, the company reported total net sales $2,630 million compared to $2,202 million a year ago. Loss from operations was $157 million compared to $289 million a year ago. Loss from continuing operations before income taxes was $250 million compared to $341 million a year ago. Loss from continuing operations including portion attributable to non-controlling interest was $163 million compared to $239 million a year ago. Net loss attributable to the company of $156 million or $0.31 per diluted share compared with $249 million or $0.47 per diluted share in the same period last year. Basic and diluted loss from continuing operations attributable to the company was $0.31 compared to $0.47 in the same period last year. LBIT was $176 million compared to $330 million a year ago. For the year, the company reported total net sales $15,855 million compared to $14,861 million a year ago. Income from operations was $4,075 million compared to $3,570 million a year ago. Income from continuing operations before income taxes was $3,827 million compared to $3,429 million a year ago. Income from continuing operations including portion attributable to non-controlling interest was $2,749 million compared to $2,514 million a year ago. Net income attributable to the company of $2,740 million or $5.22 per diluted share compared with $2,482 million or $4.60 per diluted share in the same period last year. Diluted income from continuing operations attributable to the company was $5.19 compared to $4.58 in the same period last year. EBIT was $3,952 million compared to $3,460 million a year ago. Net cash provided by operating activities was $3,054 million compared to $2,740 million a year ago. Capital expenditures were $1,005 million compared to $741 million a year ago. The company provided earnings guidance for the fiscal 2015. The company expects to achieve EPS of $5.75 to $6.00 in fiscal year 2015. The company's growth outlook is anchored on the continued strength of its core business, with the Seeds and Genomics segment setting the pace for overall EPS growth in fiscal year 2015. The company expects net cash provided by operating activities to be $3,200 million to $3,600 million, and free cash flow to be approximately $2,000 million to $2,200 million.

Monsanto Launches GMO Center in Mexico

Monsanto has launched a new global center in Mexico focused on developing new hybrid and genetically modified strains of corn. Monsanto plans to centralize its development of corn seed research for the U.S. market at the new center, which is based in Tlajomulco de Zuniga, Reuters reports. The aim is to create new varieties tolerant to diseases and the stresses that affect maize cultivation all over the world due to growing negative conditions caused by global climate change. The center is part of Monsanto's effort to boost its output of corn, which is the planet's most widely produced grain, according to Reuters.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MON*:MM $1,490.80 MXN 0.00

MON* Competitors

Market data is delayed at least 15 minutes.

Company Last Change
EI du Pont de Nemours & Co $69.00 USD +0.41
FMC Corp $58.12 USD -0.06
Sumitomo Chemical Co Ltd ¥359.00 JPY 0.00
Syngenta AG SFr.290.20 CHF -1.30
Dow Chemical Co/The $48.21 USD +0.53
View Industry Companies
 

Industry Analysis

MON*

Industry Average

Valuation MON* Industry Range
Price/Earnings 21.8x
Price/Sales 3.6x
Price/Book 7.3x
Price/Cash Flow 21.7x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MONSANTO CO, please visit www.monsanto.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.